EPRX – eupraxia pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months [Yahoo! Finance]
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months [Globe and Mail, The (Toronto, Canada)]
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting [Yahoo! Finance]
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 20
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 14
Form SC 13G EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 12
Form D EUPRAXIA PHARMACEUTICALS
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.